par De Santis, Maria Carmen;Campbell, Christine;Samy, Faye;De Rose, Fiorenza;Meduri, Bruno;Lambertini, Matteo;Sotiriou, Christos
;Carnevale, Maria Grazia;Ferro, Antonella;Saura, Cristina;Choudhury, Anup;Giandini, Carlotta;Verderio, Paolo;Chumsri, Saranya;Appierto, Valentina;Piccart, Martine;Pruneri, Giancarlo;Colciago, Riccardo Ray;de Azambuja, Evandro;Di Cosimo, Serena
Référence EClinicalMedicine, 98, page (104079)
Publication Publié, 2026-08-01
;Carnevale, Maria Grazia;Ferro, Antonella;Saura, Cristina;Choudhury, Anup;Giandini, Carlotta;Verderio, Paolo;Chumsri, Saranya;Appierto, Valentina;Piccart, Martine;Pruneri, Giancarlo;Colciago, Riccardo Ray;de Azambuja, Evandro;Di Cosimo, SerenaRéférence EClinicalMedicine, 98, page (104079)
Publication Publié, 2026-08-01
Article révisé par les pairs
| Résumé : | Postmastectomy radiation therapy (PMRT) improves locoregional control and survival in patients with early breast cancer, but it is unclear whether these benefits extend to human epidermal growth factor receptor 2 (HER2)-positive patients in the anti-HER2 era. |



